Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Food and Drug Administration (2005). Transcript of the Oncologic Drugs Advisory Committee. (published online 4 March 2005, at www.fda.gov/ohrms/dockets/ac/05/transcripts/2005-4095T2.htm).
Food and Drug Administration (2007a). Executive Summary for the Neurostar TMS Therapy. (published online 26 January 2007, at www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4273b1_01-FDAExecutiveSummary.pdf).
Food and Drug Administration (2007b). Transcript of the Neurological System Devices Panel. (published online 26 January 2007, at www.fda.gov/ohrms/dockets/ac/07/transcripts/2007-4273t1.rtf).
Furberg BD, Furberg CD (2007). Evaluating Clinical Research; All that Glitters is not Golden. Springer: New York.
Hayward R (2002). Users' Guides Interactive. JAMA Publishing Group: Chicago. (available online at http://www.usersguides.org).
Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A et al (2009). Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 34: 522–534 (originally published online 13 August 2008, at www.nature.com/npp/journal/v34/n2/full/npp2008118a.html).
Neuronetics (2008). Press Release- FDA Clears Neurostar TMS Therapy for the Treatment of Depression. Neuronetics: Malvern, PA. (published online 8 October 2008, at www.neuronetics.com/FDA_Clears_NeuroStarTMS_Therapy_for_the_Treatment_of_Depression.pdf).
O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z et al (2007). Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 62: 1208–1216.
Rothwell PM (2005). Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365: 176–186.
Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM (2007). Statistics in medicine; reporting of subgroup analyses in clinical trials. N Engl J Med 357: 2189–2194.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure/Conflict of Interest
We declare that, except for income received from our primary employer, no financial support of compensation has been received from any individual or corporate entity over the past 3 years for research or professional services, and there are no personal financial holdings that could be perceived as constituting a potential conflict of interest.
Rights and permissions
About this article
Cite this article
Hines, J., Lurie, P. & Wolfe, S. Post Hoc Analysis Does Not Establish Effectiveness of rTMS for Depression. Neuropsychopharmacol 34, 2053–2054 (2009). https://doi.org/10.1038/npp.2009.22
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2009.22